—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Teva Pharma Industries Ltd ADR (TEVA) — chart, structure and Closelooknet read

The Closelooknet read

Teva makes and sells generic medicines across many dosage forms alongside branded treatments for the nervous system, respiratory illness and cancer, and supplies active ingredients and contract manufacturing to other drugmakers. It licenses products to other pharmaceutical firms and has agreements with partners such as Sanofi and Alvotech.

Detail below: the desk's view, the earnings record, peers and the company snapshot; daily prices on the price-history tab. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for TEVA, from the same nightly bakes the boards use. Research diary readings, not advice.

Weather around the name 4 macro readings: Money Temperature, Factor regime, Sector × region …

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 46/100 · S&P 500 fund at 50, above its 200-day averageEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-11-02
  • Factor regime Defensive rotation — low-vol leading, regime-change watchMomentum against low volatility (SPMO / SPLV): below its 50-day trend, 76th percentile of the window, -20.6% over 20 sessions. Factor regime → 2026-11-02
  • Sector × region Health care in US: +3.0% week · +11.1% month · +14.3% quarter · +26.9% yearThe Sector Engine cell this name lives in, from XLV.US; the 11 × 4 matrix shows where its sector is being bought and where it is being sold. Sector Engine → 2026-11-02
  • Sovereign pressure Index -1.63 · down 2.22 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-11-02
How it trades on rate days beta 0.23 to TLT · on the worst bond days it held up better than the market

How it trades on rate days

How TEVA has moved when long-dated Treasury yields rise — measured against TLT, the 20+ year Treasury fund.

  • Beta to long bonds, 1 year 0.23 — shows only a loose link to bond moves for every 1% move in TLT (20+ year Treasuries), Teva Pharma Industries Ltd ADR moved 0.23% on average · correlation 0.06 · higher than 17% of US names
  • Beta, last 3 months 0.55 more rate-sensitive lately than over the year
  • On the 10 worst bond days +0.12% on average against −0.74% for the S&P 500 the 10 sessions of the past year in which TLT fell most, i.e. long yields rose most
  • Latest of those days +3.10% TLT −1.29% that day 2026-09-24

Daily total returns from the adjusted price series; a TLT down day is a day long yields rose. Beta = the average move of the name for a 1% move in TLT. Past sensitivity, not a forecast. An investment diary, not a recommendation.

Who it is priced against Drug Manufacturers - Specialty & Generic · US · 8 names with week and year-to-date

Peer group

Drug Manufacturers - Specialty & Generic · US

Names in the same industry from the Closelooknet universe; scored names rank on their Closelooknet score, the rest on trend state.

Compared against TEVA on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — Teva Pharma Industries Ltd ADR

TEVA in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Teva makes and sells generic medicines across many dosage forms alongside branded treatments for the nervous system, respiratory illness and cancer, and supplies active ingredients and contract manufacturing to other drugmakers. It licenses products to other pharmaceutical firms and has agreements with partners such as Sanofi and Alvotech. It is headquartered in Tel Aviv and lists in the United States as an ADR, a certificate that lets US investors hold foreign shares.
Where it sits in the stack
Teva has no seat in our index, Rubin, which tracks the AI build-out; it belongs to the diary's Healthcare sleeve, the part of our universe covering scored drugmakers rather than compute or chip layers.
Who it is priced against
Closelooknet's peer group places it with other scored Healthcare names based in the US, among them Regeneron, Vertex and BeiGene; the market also compares it with fellow generics maker Viatris.
Why Closelooknet tracks it
Teva carries a Closelooknet score built from several modules; momentum reads strongest, quality reads weakest. It holds no seat in our index and has not yet appeared in the diary's editions or quotes.
What the diary watches
The diary watches whether branded launches such as AJOVY and UZEDY keep offsetting pricing pressure in the generics business, since that balance feeds the quality module's read.

Teva Pharma Industries Ltd ADR (TEVA) trades on US exchanges, classified under Healthcare.

The Closelooknet company score reads 46/100 composite (momentum 89, quality 49, valuation 42) across 7 modules — the full breakdown, chart structure and analog history load live above.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

The Street on this name 2 analyst actions on the wire · latest: initiation by H.C. Wainwright, 2026-11-02

The Street on this name

Analyst actions and the latest print for TEVA from the Closelooknet wires — third-party opinions on the record, not our readings.

  • Initiation H.C. Wainwright — at Buy Initiated to Buy 2026-11-02
  • Price target Oppenheimer — target 50 Target set to $50 (+26.5% to spot) 2026-09-23

2 actions on the analyst wire since 2026-08-13: 1 initiation, 1 target change. Analyst wire → · Earnings wire →

Dividends and capital return no distribution in twelve months

Dividends and capital return

What TEVA pays out and buys back — distributions read from the price series, money terms from the filings.

  • Distributions No cash distribution recorded in the price series over the last three years
  • Share count +3.7% in FY2025 157 m USD of stock-based compensation in the year

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

FAQ · from the current data · as of 2026-11-03

Quick answers

What is Teva Pharma Industries Ltd ADR (TEVA)?

Teva Pharma Industries Ltd ADR trades as TEVA on the US exchange (US) and is classified under Healthcare in the Closelooknet research universe, as of the registry build of 2026-11-03.

Is TEVA in a Closelooknet index?

Not currently — Teva Pharma Industries Ltd ADR is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-11-03.

What is Teva Pharma Industries Ltd ADR's Closelooknet composite score?

46 out of 100, with momentum 89, quality 49 and valuation 42 sub-scores, as of 2026-11-03. Scores are Closelooknet's own research readings, not ratings or investment advice.

Where does TEVA trade against its moving averages?

Teva Pharma Industries Ltd ADR trades 4.0% above its 50-day and 17.6% above its 200-day moving average (0.3% above its 20-day). As of 2026-11-02 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How does Teva Pharma Industries Ltd ADR compare with its peers?

Against its peer group (Drug Manufacturers - Specialty & Generic · US), Teva Pharma Industries Ltd ADR (TEVA) sits 4.4% below its 52-week high, 4.0% above its 50-day average; Lantheus Holdings Inc (LNTH) is 10.3% below, GALDERMA GROUP AG (GALDY) is 1.0% below, Kiniksa Pharmaceuticals Ltd (KNSA) is 7.8% below, as of 2026-11-02. Put any of them next to TEVA in the chart grid (2×1 or 2×2) and the page lays the companies side by side: performance, trend, valuation, margins and our money-flow reading.

How does Teva Pharma Industries Ltd ADR trade when bond yields rise?

Over the past year Teva Pharma Industries Ltd ADR had a beta of 0.23 to TLT, the long-dated Treasury fund — it shows only a loose link to bond moves, higher than 17% of US names. On the 10 sessions in which long bonds fell most it moved +0.12% on average, against −0.74% for the S&P 500. As of 2026-11-02; The "How it trades on rate days" block on this page carries the lines.

What does Teva Pharma Industries Ltd ADR do?

Teva makes and sells generic medicines across many dosage forms alongside branded treatments for the nervous system, respiratory illness and cancer, and supplies active ingredients and contract manufacturing to other drugmakers. It licenses products to other pharmaceutical firms and has agreements with partners such as Sanofi and Alvotech. It is headquartered in Tel Aviv and lists in the United States as an ADR, a certificate that lets US investors hold foreign shares. Closelooknet's peer group places it with other scored Healthcare names based in the US, among them Regeneron, Vertex and BeiGene; the market also compares it with fellow generics maker Viatris. (Company snapshot of 2026-09-17.)

Where does Teva Pharma Industries Ltd ADR sit in the AI build-out?

Teva has no seat in our index, Rubin, which tracks the AI build-out; it belongs to the diary's Healthcare sleeve, the part of our universe covering scored drugmakers rather than compute or chip layers. Teva carries a Closelooknet score built from several modules; momentum reads strongest, quality reads weakest. It holds no seat in our index and has not yet appeared in the diary's editions or quotes. (Company snapshot of 2026-09-17.)

Does Teva Pharma Industries Ltd ADR pay a dividend?

No cash distribution shows in Teva Pharma Industries Ltd ADR’s price series over the last three years. The share count rose 3.7% over the fiscal year. As of 2026-11-02; the "Dividends and capital return" block on this page carries the lines.

What has Wall Street done on Teva Pharma Industries Ltd ADR recently?

The most recent analyst action on Teva Pharma Industries Ltd ADR on the Closelooknet wire is a initiation by H.C. Wainwright on 2026-11-02 (at Buy). 2 actions on the analyst wire since 2026-08-13: 1 initiation, 1 target change. Analyst actions are third-party opinions recorded by the wire, not Closelooknet readings. The “The Street on this name” block on this page lists the moves; the full feeds are the analyst wire and the earnings wire.

What does this page show?

A live price chart with SMA overlays and drawing tools for TEVA, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

How to use this chart

Toolbar

  • Range — 1M to MAX on daily closes. 1D/5D switch a US stock cell to 5-minute intraday bars; index and foreign cells fall back to 1M daily with a note.
  • Grid — 1×1 up to 2×2. Cells are synchronized: pan or zoom one and the others follow the same dates; the crosshair tracks across all of them. 4 INDICES loads Rubin · HALO · AEI · AW40 side by side.
  • Type / Scale — OHLC, line or area; linear or log price axis.

Picking a series

  • Tap the box in a cell's header to browse every Closelooknet series — headline indices, sub-indices, sectors, layers of all six families — plus the constituents.
  • Or type any ticker (NVDA, 7203.T, ASML.AS …) and press Enter — it charts in the cell straight from our data lake.

Studies

  • Overlays / Oscillators rows toggle the standard set (SMA, Bollinger, RSI, MACD …) per cell.
  • Levels (stock cells) draws the structure engine's support lines — regression bands, pivot cluster, SMA-200, the active fib zone.

Drawing

  • Tap a tool (Trend, Ray, H-Line, Fib, Channel, Rect, Note), then tap the chart once per point — the shape follows your finger or cursor between taps. The chart stops panning while a tool is armed; tap the tool again to release.
  • Drawings save per symbol in this browser and travel between the terminal and the asset page.
  • Delete key removes the selected drawing · Escape cancels a half-placed one · Clear wipes the symbol.

Wave counts

  • Wave places an Elliott count: tap the origin, then each wave end. Press Enter to stop early (inside wave 3 is fine) — dotted ghost targets sketch the remaining waves at guideline ratios.
  • On stocks the scanner's machine count appears automatically in grey — it is fully editable: drag any point, double-tap a label to remove it, Delete to dismiss it for good, Adopt to bring the machine's proposal back.
  • The sequence picker switches 1-5 / A-B-C / A-E / W-X-Y-Z; 1 2 3 cycles the degree; Subdiv starts a one-degree-smaller child count inside a wave.

Sharing

  • Card exports the cell as a branded PNG — chart, drawings and levels exactly as shown.

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.